rLCMV/WE-GP (+ Glycan 5)
Glc5 is introduced in LCMV-GP thus mimicking LASV glycosylation. rLCMV+Glc5 is ≥100-fold less sensitive to KL25 or WEN3 neutralization than WT virus.
Product Risk Group:
Infectivity tested and quantified
1 vial containing 1 ml
(Cost per access for Academics)